Transderm Scop (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Transderm Scop drug offered from Baxter Healthcare Corporation. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | Scopalamine |
SUBSTANCE NAME: | SCOPOLAMINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | PATCH, EXTENDED RELEASE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2003-01-01 |
END MARKETING DATE: | 0000-00-00 |
Transderm Scop HUMAN PRESCRIPTION DRUG Details:
Item Description | Transderm Scop from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/3d) |
START MARKETING DATE: | 2003-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10019-553_9caea3f4-e7e2-4d24-b3b6-5e62f37b3ec8 |
PRODUCT NDC: | 10019-553 |
APPLICATION NUMBER: | NDA017874 |
Other SCOPOLAMINE Pharmaceutical Manufacturers / Labelers: